Galera Therapeutics, Inc. (GRTX) Interest Expense USD 2019 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Galera Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from 2019 to 2024.
  • Galera Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $0.000, a 100% decline year-over-year.
  • Galera Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $7.19 M, a 46.7% decline year-over-year.
  • Galera Therapeutics, Inc. annual Interest Expense for 2023 was $11.4 M, a 1.36% decline from 2022.
  • Galera Therapeutics, Inc. annual Interest Expense for 2022 was $11.6 M, a 60.8% increase from 2021.
  • Galera Therapeutics, Inc. annual Interest Expense for 2021 was $7.19 M, a 47.4% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $7.19 M $0 -$4.22 M -100% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $11.4 M $4.88 M +$1.56 M +46.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $9.86 M -$2.09 M -$5.33 M -164% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $15.2 M $4.4 M +$1.7 M +63% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $13.5 M $4.22 M +$1.92 M +83.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $11.6 M $3.32 M +$1.01 M +43.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $10.6 M $3.25 M +$918 K +39.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $9.64 M $2.7 M +$1.4 M +107% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $8.24 M $2.3 M +$1.05 M +83.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $7.19 M $2.31 M +$1.06 M +84.2% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-08
Q3 2021 $6.14 M $2.33 M +$1.09 M +88.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $5.05 M $1.3 M +$7 K +0.54% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $5.04 M $1.25 M +$158 K +14.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $4.88 M $1.26 M +$317 K +33.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $4.56 M $1.24 M +$317 K +34.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $4.25 M $1.3 M +$559 K +76% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 $3.69 M $1.1 M +$656 K +149% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q4 2019 $3.03 M $938 K Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $918 K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $736 K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $439 K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.